“LUMIER PHARMA” LLC Successfully Delivered Medicinal Products to International Organizations UNDP and Crown Agents Within the Framework of Tenders Held for the Ministry of Health of Ukraine
In 2017 “LUMIER PHARMA” LLC, as a socially responsible company, successfully delivered medicinal products to international organizations UNDP and Crown Agents within the framework of tenders held for the Ministry of Health of Ukraine for the funds of the state budget 2016:
- PEGFERON, solution for injection 180 μg / 1 ml for 1 ml in vials № 1, № 4 - for the treatment of chronic hepatitis B and C.
- RITUXIM, a concentrate for the preparation of infusion solution in vials of 100mg/10 ml and 500mg/50 ml – for the treatment of non-Hodgkin's lymph, chronic lymphatic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis.
- TRASTUMAB, powder for the preparation of concentrate for infusion, in vials of 150 mg each – for the treatment of HER-2 positive metastatic or early breast cancer.
- UNITRON, lyophilized powder for solution for injection at 50 μg /0.5 ml, 80 μg /0.5 ml, 100 μg /0.5 ml, 120 μg /0.5 ml, 150 μg /0.5 ml in vials complete with a solvent; in a two-chamber syringe pen (redipen) with a solvent - for the treatment of chronic hepatitis B and C.
Considerable possibilities and experience of the international organizations in the sphere of procurement of medicinal products and medical devices make it possible to use budgetary funds transparently and efficiently and, what is more important, to ensure quality treatment for patients in Ukraine.
13 December 2017